These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer]. Saisho S, Saeki T, Takashima S, Aogi K, Ohsumi S. Gan To Kagaku Ryoho; 2003 Dec; 30(13):2063-8. PubMed ID: 14712766 [Abstract] [Full Text] [Related]
28. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion. Matsuzaki Y, Shibata K, Yoshioka M, Inoue M, Sekiya R, Onitsuka T, Iwamoto I, Koga Y. Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311 [Abstract] [Full Text] [Related]
30. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion]. Kawaoka T, Yoshino S, Hazama S, Tangoku A, Oka M. Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464 [Abstract] [Full Text] [Related]
31. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism]. Kang M, Zhou L, Lin P. Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704 [Abstract] [Full Text] [Related]
32. [Response and pharmacokinetics of cisplatin instilled into the pleural cavity]. Kudoh S, Takifugi N, Ryu S, Sakai N, Matsui K, Negoro S, Tamai S, Takada M, Kusunoki Y, Fukuoka M. Gan To Kagaku Ryoho; 1985 Nov; 12(11):2161-5. PubMed ID: 4062316 [Abstract] [Full Text] [Related]
33. [Negative pleural cytology after intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion]. Yagi T, Ueda K, Kaneda Y, Sakano H, Tanaka T, Matsuoka T, Sudo M, Hayashi M, Hamano K. Kyobu Geka; 2004 Feb; 57(2):107-10. PubMed ID: 14978902 [Abstract] [Full Text] [Related]
34. [A preliminary report on the treatment of pleural carcinomatosis with SMANCS]. Kimura M, Kaneda H, Kume S, Matsushita H, Inoue M, Kai M, Takeuchi H, Uemura K. Gan To Kagaku Ryoho; 2001 Jul; 28(7):1023-5. PubMed ID: 11478133 [Abstract] [Full Text] [Related]
35. Re: Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion, by Muraoka M, Oka T, Akamine S, et al. Johnstone DW. J Surg Oncol; 2006 Mar 15; 93(4):255-6. PubMed ID: 16496362 [No Abstract] [Full Text] [Related]
36. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K. Chemotherapy; 1999 Mar 15; 45(3):197-204. PubMed ID: 10224342 [Abstract] [Full Text] [Related]
37. [Clinical treatment with cisplatin (CDDP) in pleural cavity for carcinomatous pleurisy--study of intraarterial concentration]. Hara S, Tagawa Y, Tsuji H, Oka T, Morinaga M, Shingu H, Nagayasu T, Ikuta Y, Ayabe H. Gan To Kagaku Ryoho; 1996 Sep 15; 23(11):1509-11. PubMed ID: 8854792 [Abstract] [Full Text] [Related]
39. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer]. Gu LJ, Wang WJ. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul 15; 26(7):1023-6. PubMed ID: 16864104 [Abstract] [Full Text] [Related]